Antibe Therapeutics Inc.

TSX:ATE.TO

0.29 (CAD) • At close April 8, 2024
Bedrijfsnaam Antibe Therapeutics Inc.
Symbool ATE.TO
Munteenheid CAD
Prijs 0.295
Beurswaarde 15,637,773
Dividendpercentage 0%
52-weken bereik 0.15 - 1.23
Industrie Medical Devices
Sector Healthcare
CEO Mr. Daniel Marcel Legault J.D., L.L.B.
Website https://www.antibethera.com

An error occurred while fetching data.

Over Antibe Therapeutics Inc.

Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs. Its lead

Vergelijkbare Aandelen

Nova Leap Health Corp. logo

Nova Leap Health Corp.

NLH.V

0.29 CAD

Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc.

EPRX.TO

3.5 CAD

Helix BioPharma Corp. logo

Helix BioPharma Corp.

HBP.TO

0.9 CAD

Financiële Gegevens

Cijfers zijn in miljoenen (CAD)

Cijfers zijn in miljoenen (CAD)